Company Filing History:
Years Active: 2025
Title: Jhansi L Magisetty: Innovator in Hemophilic Arthropathy Treatment
Introduction
Jhansi L Magisetty is a notable inventor based in Tyler, TX (US). She has made significant contributions to the field of medical science, particularly in the treatment of hemophilic arthropathy. Her innovative approach has the potential to improve the quality of life for individuals suffering from this condition.
Latest Patents
Jhansi L Magisetty holds a patent for her work titled "Treatment and prevention of hemophilic arthropathy with an antibody against endothelial cell protein C receptor (EPCR)." This patent involves the use of an antibody, preferably a blocking antibody, and most preferably a monoclonal antibody (mAb), specific for human endothelial cell protein C receptor (EPCR). The antibodies, such as mAbs JRK 1494 or JRK 1535, are designed to reduce or attenuate joint swelling, macrophage infiltration, iron deposition, and blood vessel formation, thereby treating arthropathy in hemophilic subjects. She has 1 patent to her name.
Career Highlights
Jhansi L Magisetty is affiliated with the University of Texas System, where she continues her research and development in the medical field. Her work is characterized by a commitment to advancing treatment options for patients with hemophilia.
Collaborations
Jhansi collaborates with esteemed colleagues, including Vijaya M Lella and Usha R Pendurthi, who contribute to her research endeavors and enhance the impact of her work.
Conclusion
Jhansi L Magisetty's innovative contributions to the treatment of hemophilic arthropathy highlight her dedication to improving patient outcomes. Her patent and ongoing research signify a promising advancement in medical science.